Patent · US Active

HLA-A2 tumor associated antigen peptides and compositions

US9394350B2 · kind B2 · utility

2Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 15, 2013
Grant dateJul 19, 2016
Priority date—
Expiry dateJan 18, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A peptide or composition comprising at least one HLA-A2 epitope or analog from CEA, HER2/neu, MAGE2, MAGE3, or p53.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.